Gilead to Donate More than Million Doses of its Experimental Anti-Coronavirus Drug
Global pharma major Gilead is to donate 1.5 million doses of its experimental anti-coronavirus drug remdesivir, which could treat 140,000 patients. Daniel O’Day , Chairman and Chief Executive Officer, Gilead Sciences Inc., said in an…
Read More...
Read More...